Trial intelligence / Profile preview

Efficacy of 67% Sodium Bicarbonate Dentifrice on Gingivitis and Plaque

NCT05654662Completed

Sponsor
Haleon
Start
Feb 2023
Primary completion
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of Corsodyl Original Dentifrice in gingivitis and dental plaque (2 arms), sponsored by Haleon. Primary endpoint: Adjusted Mean Change From Baseline in Number of Bleeding Sites at 12 weeks. Started Feb 2023; status: completed.

02

Drugs

Corsodyl Original Dentifrice
03

Conditions

gingivitisdental plaque

Beyond the preview

Go deeper on NCT05654662.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05654662.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call